| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |